Gene:
TGM2
transglutaminase 2

PharmGKB contains no prescribing info for this . Contact us to report known genotype-based dosing guidelines, or if you are interested in developing guidelines.

PharmGKB has no annotated drug labels with pharmacogenomic information for this . If you know of a drug label with PGx, send us a message.

PharmGKB contains no Clinical Variants that meet the highest level of criteria.

Disclaimer: The PharmGKB's clinical annotations reflect expert consensus based on clinical evidence and peer-reviewed literature available at the time they are written and are intended only to assist clinicians in decision-making and to identify questions for further research. New evidence may have emerged since the time an annotation was submitted to the PharmGKB. The annotations are limited in scope and are not applicable to interventions or diseases that are not specifically identified.

The annotations do not account for individual variations among patients, and cannot be considered inclusive of all proper methods of care or exclusive of other treatments. It remains the responsibility of the health-care provider to determine the best course of treatment for a patient. Adherence to any guideline is voluntary, with the ultimate determination regarding its application to be made solely by the clinician and the patient. PharmGKB assumes no responsibility for any injury or damage to persons or property arising out of or related to any use of the PharmGKB clinical annotations, or for any errors or omissions.

? = Mouse-over for quick help

Overview

Alternate Names:  C polypeptide, protein-glutamine-gamma-glutamyltransferase
Alternate Symbols:  TGC
PharmGKB Accession Id: PA36491

Details

Cytogenetic Location: chr20 : q12 - q11.23
GP mRNA Boundary: chr20 : 36756863 - 36794910
GP Gene Boundary: chr20 : 36753863 - 36804910
Strand: minus

Visualization

UCSC has a Genome Browser that you can use to view PharmGKB annotations for this gene in context with many other sources of information.

View on UCSC Browser
The mRNA boundaries are calculated using the gene's default feature set from NCBI, mapped onto the UCSC Golden Path. PharmGKB sets gene boundaries by expanding the mRNA boundaries by no less than 10,000 bases upstream (5') and 3,000 bases downstream (3') to allow for potential regulatory regions.
No related genes are available

Curated Information ?

Evidence Drug
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
cisplatin
No related diseases are available

Publications related to TGM2: 1

No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Epigenomics and Interindividual Differences in Drug Response. Clinical pharmacology and therapeutics. 2012. Ivanov M, et al. PubMed

LinkOuts

NCBI Gene:
7052
OMIM:
190196
UCSC Genome Browser:
NM_004613
RefSeq RNA:
NM_004613
NM_198951
RefSeq Protein:
NP_004604
NP_945189
RefSeq DNA:
NT_011362
UniProtKB:
TGM2_HUMAN (P21980)
Ensembl:
ENSG00000198959
GenAtlas:
TGM2
GeneCard:
TGM2
MutDB:
TGM2
ALFRED:
LO054656A
HuGE:
TGM2
Comparative Toxicogenomics Database:
7052
ModBase:
P21980
HumanCyc Gene:
HS02263
HGNC:
11778

Common Searches